Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco

Tuesday, January 6, 2009 General News J E 4
SAN CARLOS, Calif., Jan. 5 Nektar Therapeutics'(Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, isscheduled to present at the upcoming 27th Annual J.P. Morgan HealthcareConference in San Francisco at the Westin St. Francis Hotel on Tuesday,January 13, 2009 at 10:00 a.m. Pacific time (1:00 p.m. Eastern time).

The presentation will be accessible via a Webcast through a link posted onthe Investor Relations, Events Calendar section of the Nektar website: This Webcast will be available for replay untilFebruary 15, 2009.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing noveltherapeutics based on its advanced polymer conjugate technology platforms.Nektar's technology and drug development expertise have enabled nine approvedproducts for partners, which include leading biopharmaceutical companies.Nektar is also developing a robust pipeline of its own high-value therapeuticsthat addresses unmet medical needs by leveraging and expanding its technologyplatforms to improve and enable molecules. For more information on NektarTherapeutics, please visit Contacts: Jennifer Ruddock Nektar Therapeutics 650-631-4954 Susan Noonan The SAN Group 212-966-3650

SOURCE Nektar Therapeutics


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
StoryCorps, the National Oral History Project, Par...
The American Red Cross Sends Aid as Humanitarian S...